Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Shaping Microbiome R&D's Future: Is Big Pharma Missing The Boat?

Executive Summary

The White House said the Obama administration plans to spend $121m under a new initiative to push the science of the microbiome forward. But few drug makers were among those who responded to the administration's call to action to support the initiative's overarching goals.

Advertisement

Related Content

Sanger Institute Spin-Out Microbiotica To Evaluate Bacterial Mixes
Home sweet microbiome: 10,000 microbial species occupy healthy humans

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register